Education
About Us
Working with TipRanks
Follow Us
Kura Oncology (KURA)
NASDAQ:KURA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 53.88M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 53.88M | $ -849.00K | $ 0.00 | $ 0.00 | $ -194.00K |
| Operating Income | $ -193.19M | $ -165.80M | $ -139.87M | $ -131.26M | $ -91.90M |
| EBITDA | $ -169.50M | $ -150.23M | $ -134.85M | $ -129.49M | $ -88.85M |
| Net Income | $ -173.98M | $ -152.63M | $ -135.84M | $ -130.47M | $ -89.63M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 727.39M | $ 423.96M | $ 437.99M | $ 517.96M | $ 633.32M |
| Total Assets | $ 760.16M | $ 448.94M | $ 456.31M | $ 534.05M | $ 647.21M |
| Total Debt | $ 16.59M | $ 17.20M | $ 14.02M | $ 6.88M | $ 14.98M |
| Net Debt | $ -207.87M | $ -20.12M | $ -37.78M | $ -83.80M | $ -310.52M |
| Total Liabilities | $ 346.52M | $ 51.66M | $ 36.03M | $ 27.44M | $ 36.31M |
| Stockholders' Equity | $ 413.64M | $ 397.27M | $ 420.28M | $ 506.61M | $ 610.90M |
| Cash Flow | |||||
| Free Cash Flow | $ 133.84M | $ -124.99M | $ -110.69M | $ -105.70M | $ -72.00M |
| Operating Cash Flow | $ 134.32M | $ -124.82M | $ -110.06M | $ -104.55M | $ -69.83M |
| Investing Cash Flow | $ -101.59M | $ 15.56M | $ 32.63M | $ -126.83M | $ -99.94M |
| Financing Cash Flow | $ 154.42M | $ 94.78M | $ 38.56M | $ -3.44M | $ 469.33M |